SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005201-19-000127
Filing Date
2019-11-12
Accepted
2019-11-12 16:36:48
Documents
1
Period of Report
2019-11-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_157359459340374.html 4  
1 FORM 4 wf-form4_157359459340374.xml 4 3757
  Complete submission text file 0001005201-19-000127.txt   5215
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Issuer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 863 C MITTEN ROAD BURLINGAME CA 94010
Business Address
STAPLE PETER D (Reporting) CIK: 0001271088 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13111 | Film No.: 191210143